StreetInsider.com News Articles

Neuronetics appoints Robert Greene as senior vice president sales

Tue, 02 Jun 2026 16:30:15 -0400

Neuronetics Inc. (NASDAQ: STIM) announced the appointment of Robert Greene as senior vice president sales, effective June 1, 2026, according to a company press release.

Greene brings experience in commercial strategy and sales organizations within healthcare and medical technology sectors, including capital equipment and service areas.

The company's compensation committee authorized a restricted stock unit grant representing 200,000 shares of common stock in connection with Greene's hiring under Nasdaq Listing Rule 5635(c)(4). The grant will vest in four equal annual installments on each anniversary of the grant date, contingent on Greene's continued employment with the company.

Neuronetics develops medical technology products for patients

Neuronetics appoints Robert Greene as senior vice president sales

Tue, 02 Jun 2026 16:30:15 -0400

Neuronetics Inc. (NASDAQ: STIM) announced the appointment of Robert Greene as senior vice president sales, effective June 1, 2026, according to a company press release.

Greene brings experience in commercial strategy and sales organizations within healthcare and medical technology sectors, including capital equipment and service areas.

Neuronetics develops medical technology products for patients

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Tue, 02 Jun 2026 16:30:00 -0400

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced that Robert Greene has been appointed as the company’s Senior Vice President Sales, effective June 1, 2026.

Rob brings extensive experience leading commercial strategy and sales organizations within healthcare and medical technology, including capital equipment and service.

Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

In connection with his hiring on June 1, 2026,

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Tue, 02 Jun 2026 16:30:00 -0400

Rob brings extensive experience leading commercial strategy and sales organizations within healthcare and medical technology, including capital equipment and service.

Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

In connection with his hiring on June 1, 2026,

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Tue, 02 Jun 2026 16:30:00 -0400

Rob brings extensive experience leading commercial strategy and sales organizations within healthcare and medical technology, including capital equipment and service.

Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

In connection with his hiring on June 1, 2026,

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Tue, 02 Jun 2026 16:30:00 -0400

Rob brings extensive experience leading commercial strategy and sales organizations within healthcare and medical technology, including capital equipment and service.

Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

In connection with his hiring on June 1, 2026,

Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

Tue, 02 Jun 2026 08:32:00 -0400

New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced its participation as a Silver Sponsor at the 2026 Clinical TMS Society (CTMSS) Annual Meeting, where real-world data from the Company’s proprietary TrakStar database will be featured in an oral presentation and multiple scientific posters focused

Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

Tue, 02 Jun 2026 08:32:00 -0400

New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced its participation as a Silver Sponsor at the 2026 Clinical TMS Society (CTMSS) Annual Meeting, where real-world data from the Company’s proprietary TrakStar database will be featured in an oral presentation and multiple scientific posters focused

Form SD Neuronetics, Inc.

Fri, 29 May 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260529/26576714.html

Form SD Neuronetics, Inc.

Fri, 29 May 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260529/26576714.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: Rosengarten Megan

Fri, 29 May 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260529/26576473.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: Rosengarten Megan

Fri, 29 May 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260529/26576473.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: MUIR GLENN P

Fri, 29 May 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260529/26576397.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: MUIR GLENN P

Fri, 29 May 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260529/26576397.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: Cucuz Sasha

Fri, 29 May 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260529/26576373.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: Cucuz Sasha

Fri, 29 May 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260529/26576373.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: CONLEY SHERYL L

Fri, 29 May 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260529/26576351.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: CONLEY SHERYL L

Fri, 29 May 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260529/26576351.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: CASCELLA ROBERT

Fri, 29 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260529/26576329.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: CASCELLA ROBERT

Fri, 29 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260529/26576329.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: Amin Avinash

Fri, 29 May 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260529/26576241.html

Form 4 Neuronetics, Inc. For: May 28 Filed by: Amin Avinash

Fri, 29 May 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260529/26576241.html

Form 8-K Neuronetics, Inc. For: May 28

Fri, 29 May 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260529/26576063.html

Form 8-K Neuronetics, Inc. For: May 28

Fri, 29 May 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260529/26576063.html

Form SCHEDULE 13D/A Neuronetics, Inc. Filed by: Chernett Jorey

Wed, 27 May 2026 10:33:00 -0400

si-local-file:///var/storage/secattach/20260527/26555341.html